225 related articles for article (PubMed ID: 22222454)
1. Leveraging structural information for the discovery of new drugs: computational methods.
Nguyen TB; Wong SE; Lightstone FC
Methods Mol Biol; 2012; 841():209-34. PubMed ID: 22222454
[TBL] [Abstract][Full Text] [Related]
2. Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy.
Sherer BA; Hull K; Green O; Basarab G; Hauck S; Hill P; Loch JT; Mullen G; Bist S; Bryant J; Boriack-Sjodin A; Read J; DeGrace N; Uria-Nickelsen M; Illingworth RN; Eakin AE
Bioorg Med Chem Lett; 2011 Dec; 21(24):7416-20. PubMed ID: 22041057
[TBL] [Abstract][Full Text] [Related]
3. Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
Ronkin SM; Badia M; Bellon S; Grillot AL; Gross CH; Grossman TH; Mani N; Parsons JD; Stamos D; Trudeau M; Wei Y; Charifson PS
Bioorg Med Chem Lett; 2010 May; 20(9):2828-31. PubMed ID: 20356737
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial property of pyrrolopyrano quinolinones and pyrroloquinolines.
Jayagobi M; Raghunathan R; Sainath S; Raghunathan M
Eur J Med Chem; 2011 Jun; 46(6):2075-82. PubMed ID: 21444131
[TBL] [Abstract][Full Text] [Related]
5. In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B.
Brvar M; Perdih A; Hodnik V; Renko M; Anderluh G; Jerala R; Solmajer T
Bioorg Med Chem; 2012 Apr; 20(8):2572-80. PubMed ID: 22444877
[TBL] [Abstract][Full Text] [Related]
6. Structure-based discovery of substituted 4,5'-bithiazoles as novel DNA gyrase inhibitors.
Brvar M; Perdih A; Renko M; Anderluh G; Turk D; Solmajer T
J Med Chem; 2012 Jul; 55(14):6413-26. PubMed ID: 22731783
[TBL] [Abstract][Full Text] [Related]
7. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.
Manchester JI; Dussault DD; Rose JA; Boriack-Sjodin PA; Uria-Nickelsen M; Ioannidis G; Bist S; Fleming P; Hull KG
Bioorg Med Chem Lett; 2012 Aug; 22(15):5150-6. PubMed ID: 22814212
[TBL] [Abstract][Full Text] [Related]
9. A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
Angehrn P; Goetschi E; Gmuender H; Hebeisen P; Hennig M; Kuhn B; Luebbers T; Reindl P; Ricklin F; Schmitt-Hoffmann A
J Med Chem; 2011 Apr; 54(7):2207-24. PubMed ID: 21388139
[TBL] [Abstract][Full Text] [Related]
10. The role of enzymology in a structure-based drug discovery program: bacterial DNA gyrase.
Cunningham ML
Methods Mol Biol; 2012; 841():179-207. PubMed ID: 22222453
[TBL] [Abstract][Full Text] [Related]
11. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.
Lübbers T; Angehrn P; Gmünder H; Herzig S
Bioorg Med Chem Lett; 2007 Aug; 17(16):4708-14. PubMed ID: 17632001
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
Li Q; Chu DT; Claiborne A; Cooper CS; Lee CM; Raye K; Berst KB; Donner P; Wang W; Hasvold L; Fung A; Ma Z; Tufano M; Flamm R; Shen LL; Baranowski J; Nilius A; Alder J; Meulbroek J; Marsh K; Crowell D; Hui Y; Seif L; Melcher LM; Plattner JJ
J Med Chem; 1996 Aug; 39(16):3070-88. PubMed ID: 8759628
[TBL] [Abstract][Full Text] [Related]
15. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
[TBL] [Abstract][Full Text] [Related]
16. Application of SBDD to the discovery of new antibacterial drugs.
Finn J
Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
[TBL] [Abstract][Full Text] [Related]
18. Structure-based approaches to antibiotic drug discovery.
Nicola G; Abagyan R
Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
[TBL] [Abstract][Full Text] [Related]
19. Amycolamicin: a novel broad-spectrum antibiotic inhibiting bacterial topoisomerase.
Sawa R; Takahashi Y; Hashizume H; Sasaki K; Ishizaki Y; Umekita M; Hatano M; Abe H; Watanabe T; Kinoshita N; Homma Y; Hayashi C; Inoue K; Ohba S; Masuda T; Arakawa M; Kobayashi Y; Hamada M; Igarashi M; Adachi H; Nishimura Y; Akamatsu Y
Chemistry; 2012 Dec; 18(49):15772-81. PubMed ID: 23129443
[TBL] [Abstract][Full Text] [Related]
20. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
